Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
05 Apr 2024 07:30 CEST |
WENDEL | WENDEL: Wendel successfully completes the sale of 9% of Bureau Veritas’ share capital | 30202000 Diversified Financial Services | Mergers, Acquiqitions, Transferts |
05 Apr 2024 07:30 CEST |
Storebrand ASA | STOREBRAND ASA: Eks. utbytte NOK 4,10 i dag | 30301010 Life Insurance | Eks.dato |
05 Apr 2024 07:30 CEST |
PHOTOCURE | Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference | 20103015 Pharmaceuticals | Non-regulatory press releases |
05 Apr 2024 07:30 CEST |
Storebrand ASA | STOREBRAND ASA: Ex dividend NOK 4.10 today | 30301010 Life Insurance | Ex Date |
05 Apr 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale | 20103010 Biotechnology | New |
05 Apr 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
05 Apr 2024 07:30 CEST |
Jæren Sparebank | Forstanderskapsmøte - godkjenning av årsregnskap 2023 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
05 Apr 2024 07:30 CEST |
Pareto Bank ASA | Ex utbytte NOK 3,90 i dag | 30101010 Banks | Eks.dato |
05 Apr 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma annonce l’initiation de la couverture de son titre par Gilbert Dupont / Groupe Société Générale | 20103010 Biotechnology | New |
05 Apr 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
05 Apr 2024 07:30 CEST |
Pareto Bank ASA | Ex-dividend NOK 3,90 today | 30101010 Banks | Ex Date |
05 Apr 2024 07:01 CEST |
BIOMERIEUX | bioMérieux and Mérieux NutriSciences partner with key food industry players to launch a new collaborative data-driven model | 20102010 Medical Equipment | Other subject |
05 Apr 2024 07:01 CEST |
BIOMERIEUX | bioMérieux et Mérieux NutriSciences s\'associent à des acteurs clés de l\'industrie agroalimentaire pour lancer un nouveau modèle de collaboration, basé sur les données | 20102010 Medical Equipment | Other subject |
05 Apr 2024 07:00 CEST |
ENSURGE MICROPOWER ASA | Ensurge Micropower ASA - EX. AKSJESPLEIS I DAG | 50202040 Electronic Equipment: Other | Ex Date |
05 Apr 2024 07:00 CEST |
ENSURGE MICROPOWER ASA | Ensurge Micropower ASA - EX. SHARE CONSOLIDATION TODAY | 50202040 Electronic Equipment: Other | Ex Date |
05 Apr 2024 07:00 CEST |
HOEGH AUTOLINERS ASA | Höegh Autoliners ASA (HAUTO) – March 2024 Trading Update | 50206030 Marine Transportation | Non-regulatory press releases |
05 Apr 2024 07:00 CEST |
ELEKTROIMPORTØREN AS | Elektroimportøren AS: Last day of subscription period in the Subsequent Offering | 40401030 Specialty Retailers | Additional regulated information required to be disclosed under the laws of a Member State |
05 Apr 2024 07:00 CEST |
VOLUE ASA | Volue publishes its 2023 Annual Report and ESG Report | 10101015 Software | Annual financial and audit Reports |
05 Apr 2024 06:30 CEST |
Lerøy Seafood Group ASA | Lerøy Seafood Group ASA: Trading update Q1 2024 | 45102010 Farming, Fishing, Ranching and Plantations | Half yearly financial reports and audit reports/limited reviews |
05 Apr 2024 06:30 CEST |
Lerøy Seafood Group ASA | Lerøy Seafood Group ASA: Oppdatering volum i første kvartal 2024 | 45102010 Farming, Fishing, Ranching and Plantations | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
05 Apr 2024 01:33 CEST |
CELLECTIS | CORRECTION : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social | 20103010 Biotechnology | - |
04 Apr 2024 23:00 CEST |
- | RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024 | - | General meeting / Board Meeting |
04 Apr 2024 23:00 CEST |
- | RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024 | - | General meeting / Board Meeting |
04 Apr 2024 23:00 CEST |
CLARANOVA | Claranova: Availability of the FY 2023-2024 Half-Year Financial Report Final FY 2023-2024 half-year financial statements | 10101015 Software | Income |
04 Apr 2024 23:00 CEST |
BIOPHYTIS | RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 23:00 CEST |
CLARANOVA | Claranova : Mise à disposition du Rapport Financier Semestriel 2023-2024 Comptes semestriels 2023-2024 définitifs | 10101015 Software | Income |
04 Apr 2024 23:00 CEST |
BIOPHYTIS | RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 2 AVRIL 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:43 CEST |
DBV TECHNOLOGIES | Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:43 CEST |
DBV TECHNOLOGIES | Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:30 CEST |
CELLECTIS | Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social | 20103010 Biotechnology | - |
04 Apr 2024 22:30 CEST |
CELLECTIS | Monthly information on share capital and company voting rights | 20103010 Biotechnology | - |
04 Apr 2024 22:22 CEST |
Euronav Luxembourg SA 21/26 6.25pct USD C | Disclosure regarding a transparency notification | - | Additional regulated information required to be disclosed under the laws of a Member State |
04 Apr 2024 22:15 CEST |
EURONAV | Disclosure regarding a transparency notification | 50206030 Marine Transportation | Other subject |
04 Apr 2024 22:15 CEST |
EURONAV | Openbaarmaking van een transparantiekennisgeving | 50206030 Marine Transportation | Other subject |
04 Apr 2024 22:10 CEST |
GENFIT | GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:10 CEST |
GENFIT | GENFIT : Résultats financiers annuels 2023 et point sur les activités de la Société | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:01 CEST |
GALAPAGOS | Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:01 CEST |
GALAPAGOS | Galapagos toont innovatieve aanpak in hematologische kankerzorg met presentaties over klinische en translationele data op EBMT congres 2024 | 20103010 Biotechnology | Other subject |
04 Apr 2024 22:00 CEST |
CLARANOVA | Nombre d’actions et droits de vote composant le capital social de Claranova au 31 mars 2024 | 10101015 Software | Other subject |
04 Apr 2024 21:59 CEST |
SES | SES Shareholders Vote at Annual General Meeting and Extraordinary General Meeting | 15101010 Telecommunications Equipment | Other subject |
04 Apr 2024 21:50 CEST |
BIC | BIC : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mars 2024 | 45201030 Nondurable Household Products | Share history |
04 Apr 2024 21:50 CEST |
BIC | Bic: Disclosure of total number of voting rights and number of shares forming the capital as of March 31, 2024 | 45201030 Nondurable Household Products | Share history |
04 Apr 2024 21:45 CEST |
SALMONES CAMANCHACA S.A. | Integrated Annual Report 2023 | 45102010 Farming, Fishing, Ranching and Plantations | Annual financial and audit Reports |
04 Apr 2024 21:30 CEST |
Storebrand ASA | STOREBRAND ASA - Annual General Meeting 2024 concluded | 30301010 Life Insurance | Additional regulated information required to be disclosed under the laws of a Member State |
04 Apr 2024 21:30 CEST |
Storebrand ASA | STOREBRAND ASA - Ordinær generalforsamling 2024 avholdt | 30301010 Life Insurance | Annen informasjonspliktig regulatorisk informasjon |
04 Apr 2024 21:12 CEST |
GENSIGHT BIOLOGICS | GenSight Biologics Reports Cash Position as of March 31, 2024, and Provides Business Update | 20103010 Biotechnology | Commercial operations |
04 Apr 2024 21:12 CEST |
GENSIGHT BIOLOGICS | GenSight Biologics publie sa situation nette de trésorerie au 31 mars 2024, et fait le point sur ses activités | 20103010 Biotechnology | Commercial operations |
04 Apr 2024 21:05 CEST |
NORTHERN DRILLING | NODL: CEO resignation | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
04 Apr 2024 21:02 CEST |
NORTHERN OCEAN LTD. | NOL: CEO resignation | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
04 Apr 2024 20:56 CEST |
NORCOD | NORCOD AS: Preliminary result of Subsequent Offering | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |